Bridge Study: Bridging Anticoagulation
The Bridge study will determine whether a bridging blood thinner called dalteparin is helpful or harmful for people with atrial fibrillation who stop taking warfarin in preparation for surgery or another procedure.
In order to participate you must meet the following criteria:
- Are 18 years of age or older.
- Have chronic atrial fibrillation.
- Have been treated with Coumadin for at least three months.
This is a partial list of eligibility criteria.